NCT06457711

Brief Summary

Obesity is a significant health issue that increases the risk of serious cardiovascular problems. In recent years, two dietary methods, the Ketogenic Diet (KD) and Intermittent Fasting (IF), have become popular for their potential to treat obesity and its related issue, hypertension. While both diets are known for their effectiveness in weight loss, their specific impacts on blood pressure (BP) and overall heart health risks are less understood especially in menopausal women. The main goal of this study was to investigate how the Ketogenic Diet and Intermittent Fasting compare to a regular, unrestricted diet (referred to as Free Diet or FD) in terms of their effects on clinic blood pressure levels in menopausal women. Additionally, the study looked at changes in Body Mass Index (BMI), the percentage of total body weight loss, body fat percentage, waist and hip measurements, the ratio of waist-to-hip size, and the Phase Angle (PhA), which is a measure of the body's overall health status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

June 1, 2024

Last Update Submit

July 13, 2024

Conditions

Keywords

blood pressuredietmenopausewomencardiometabolic risk

Outcome Measures

Primary Outcomes (1)

  • Clinic systolic brachial BP levels.

    The primary aim was to evaluate the effects of Very low calorie Ketogenic Diet or intermittent fasting compared to Free Diet on clinic systolic brachial BP levels (mmHg).

    6 months

Secondary Outcomes (5)

  • Body composition: BMI

    6 months

  • Body composition: Fat mass (%)

    6 months

  • Body composition: circumference

    6 months

  • Body Composition: Bioelectrical impedance analysis (BIA)

    6 months

  • Clinic diastolic brachial BP levels.

    6 months

Study Arms (3)

Free diet Group (FDG)

OTHER

participants were offered nutritional guidance without strict limitations, but were encouraged to adhere to the principles of the Mediterranean diet and follow the dietary recommendations outlined in Harvard's Healthy Eating Plate.

Dietary Supplement: Free diet Group (FDG)

Very low Calorie Ketogenic Diet Group (VLCKDG)

EXPERIMENTAL

the very low-calorie ketogenic diet (VLCKD) protocol involved limited carbohydrate consumption to less than 30 grams per day. The protocol suggested a protein intake ranging from 1 to 1.5 grams per kilogram of ideal body weight, with fats limited to 15-30 grams per day and total daily calories estimated between 600 and 800 kcal. During the initial three-week phase of the diet, participants replaced two meals per day with meal replacements-specifically, breakfast and one other main meal were substituted with a protein shake. Accompanying the shake for the main meal were low-glycemic-index vegetables in prescribed quantities.

Dietary Supplement: Very low Calorie Ketogenic Diet Group (VLCKDG)

Intermittent Fasting Group (IFG)

ACTIVE COMPARATOR

Our participant followed an intermittent fasting schedule, specifically the 16/8 method, which involves eating only during an eight-hour window each day and fasting for the subsequent sixteen hours. This eating period began at 12:00 noon and ended at 8:00 PM. During this window, the patient consumed three meals, each with a caloric value reduced by 25% from their total daily energy expenditure. The meals were based on the Mediterranean diet, focusing on the balance and quality of macronutrients.

Dietary Supplement: Intermittent Fasting Group (IFG)

Interventions

Free diet Group (FDG)DIETARY_SUPPLEMENT

Participants were offered nutritional guidance and were encouraged to adhere to the principles of the Mediterranean diet and follow the dietary recommendations outlined in Harvard's Healthy Eating Plate.

Free diet Group (FDG)

Participants were offered nutritional guidance and were encouraged to adhere to the principles of the very low-calorie ketogenic diet (VLCKD) protocol

Very low Calorie Ketogenic Diet Group (VLCKDG)

Participants were offered nutritional guidance and were encouraged to adhere to the principles of the intermittent fasting schedule

Intermittent Fasting Group (IFG)

Eligibility Criteria

Age50 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female individuals,
  • aged between 50 and 65 years,
  • BMI ≥25 kg/m2;
  • diagnosis of essential uncomplicated arterial hypertension for at least 6 months;
  • perimenopause or menopause confirmed,
  • provision of informed consent.

You may not qualify if:

  • previous history of major CVDs;
  • severe heart or renal failure;
  • poor adherence to prescribed pharmacological and non-pharmacological treatments;
  • treated uncontrolled hypertension or diabetes;
  • secondary forms of hypertension;
  • uncontrolled thyroid diseases;
  • previous bariatric surgery or endoscopic bariatric procedures;
  • regular engagement in competitive sports activities;
  • history of alcoholism and/or drug addiction;
  • psychiatric and/or neurological conditions affecting the understanding and giving of informed consent;
  • cancer or any other progressive severe disease;
  • use of pharmacological treatments known to may interfere with the main purposes of the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sapienza University of Rome

Rome, RM, 00189, Italy

Location

MeSH Terms

Conditions

HypertensionObesityMetabolic SyndromeCardiovascular Diseases

Condition Hierarchy (Ancestors)

Vascular DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
Collaborative consultation encouraged patients to participate. Patient can choose their group of intervention. Dietary regimen were tailored on each patient: the intervention was adapted to patients' needs and to their body composition.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The investigators enrolled 50 patient to divide in 20 patients in the KD group, 20 in the IF group and 10 in the FD. Seven patients dropped out from their assigned groups as follows: FD (n = 2), IF (n = 3), and KD (n = 2).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Cardiology

Study Record Dates

First Submitted

June 1, 2024

First Posted

June 13, 2024

Study Start

June 22, 2022

Primary Completion

June 22, 2023

Study Completion

June 22, 2023

Last Updated

July 16, 2024

Record last verified: 2024-07

Locations